Mobble
Health · Drug development · published 2026-08-19 · via Endpoints News

Anthropic's Claude Takes the Wheel in De Novo Protein Design

Anthropic reported that its AI model Claude autonomously managed a research effort to design and generate entirely new miniproteins. The company detailed the work in a blog post on Tuesday, highlighting Claude's role in overseeing the project from conception to generation. This suggests the lab is expanding its focus toward applying AI to biological and life-sciences challenges.

Read the full article at Endpoints News →
Related stories
MapLight Halts Early Work to Focus on Lead Candidate; ADC Therapeutics Reassesses Zynlonta · Mental health
This summary is AI-generated and original to Mobble; the linked article is the authoritative source. Original headline: “Analysis: What Anthropic's protein study says about its life-sciences aims.” Browse more stories.